Skip to main content

Imunon, Inc.

IMNN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000749647

In the last 90 days, Imunon, Inc. insiders filed 0 open-market purchases and 5 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $506.1K in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding Imunon, Inc. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of IMNN: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders1923+4
Shares503.6K318.7K−184.9K (−36.7%)
Value$1.63M$506.1K−$1.12M (−68.9%)

New holders (6)

Institutions that held Imunon, Inc. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to IMNN in Q2 2026
InstitutionSharesValue% of portfolio
Virtu Financial LLC17,456$31.0K0.00%
Northern Trust Corp10,342$18.4K0.00%
Barclays PLC194$3450.00%
JPMorgan Chase & Co134$2410.00%
Caitong International Asset Management Co., Ltd8$140.00%
Northwestern Mutual Wealth Management Co3$50.00%

Sold out (2)

Institutions that held Imunon, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of IMNN in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
HRT Financial LP12,055$35.0K
Federation des caisses Desjardins du Quebec5$15